WOONSOCKET, R.I. — CVS Pharmacy will be acquiring six Ohio outpatient pharmacy locations from ProMedica, with plans to close five of them. CVS Pharmacy will take over operations at ProMedica Pharmacy Counter in Oregon, Ohio, converting it to a CVS Pharmacy in November. The other five locations, all in the Toledo area, will be closed, with their files set to be transferred to nearby CVS Pharmacy locations starting in mid-October.
“ProMedica and CVS Pharmacy are working closely together to ensure patients experience a seamless transition of services and that their access to pharmacy care is not interrupted,” ProMedica SCP inpatient and retail pharmacy Dr. Neeraj Kanwal said. “We’re confident our patients will benefit from CVS Pharmacy’s unique clinical services.”
ProMedica is the latest in a string of regionally focused acquisitions from CVS Pharmacy. The company acquired the prescription information and information from all of Marsh Supermarkets’ 37 Indiana stores in May, followed by its acquisition and conversion to CVS Pharmacy of all 14 Doc’s Drugs locations in Illinois. In early August, the company acquired 20 Indiana and Illinois Fagen Pharmacy locations, closing 12 and converting 8 to CVS Pharmacy locations.
CVS Pharmacy said that it planned to hire many of the Pharmacy Counter employees currently working at the acquired ProMedica Pharmacy Counter locations. ProMedica is set to retain ownership of its outpatient pharmacies at three hospitals and operate its specialty, adherence and home infusion pharmacies, as well as its home medical equipment business. Patients will soon have access to CVS Pharmacy’s services, including adherence programs, automatic refills, immunizations, text alerts and digital tools.
“We’re pleased to partner with ProMedica and look forward to bringing our innovative pharmacy care programs and services to its patients in Ohio,” CVS Pharmacy area VP Alisa Ulrey said. “We are committed to continuing ProMedica and Pharmacy Counter’s tradition of providing excellent care to patients, and are excited to introduce our industry-leading offerings to patients.”